Degenerative diseases, oxidative stress and cytochrome c oxidase function

Trends in Molecular Medicine

Volumn 15, Issue 4, 2009, Pages 139-147

  Kadenbach, Bernhard ^a   Ramzan, Rabia ^a   Vogt, Sebastian ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; REACTIVE OXYGEN METABOLITE;

AGING; ALLOSTERISM; ARTICLE; CELL RESPIRATION; CRYSTAL STRUCTURE; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; OXIDATIVE STRESS; PROTEIN DEPHOSPHORYLATION; PROTON TRANSPORT; RESPIRATORY CHAIN;

ADENOSINE TRIPHOSPHATE; ANIMALS; ELECTRON TRANSPORT COMPLEX IV; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 63449139296     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2009.02.004     Document Type: Article

References (87)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
2. Harman D. A biologic clock: the mitochondria?. J. Am. Geriatr. Soc. 20 (1972) 145-147
3. Huang H., and Manton K.G. The role of oxidative damage in mitochondria during aging: a review. Front. Biosci. 9 (2004) 1100-1117
4. Dalle-Donne I., et al. Biomarkers of oxidative damage in human disease. Clin. Chem. 52 (2006) 601-623
5. Valko M., et al. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007) 44-84
6. Trachootham D., et al. Redox regulation of cell survival. Antioxid. Redox Signal. 10 (2008) 1343-1374
7. Kussmaul L., and Hirst J. The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7607-7612
8. Dröse S., and Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. J. Biol. Chem. 283 (2008) 21649-21654
9. Wan B., et al. Effects of cardiac work on electrical potential gradient across mitochondrial membrane in perfused rat hearts. Am. J. Physiol. 265 (1993) H453-H460
10. Zhang H., et al. Assessment of membrane potentials of mitochondrial populations in living cells. Anal. Biochem. 298 (2001) 170-180
11. Nicholls D.G., and Ferguson S.J. Bioenergetics 3 (2002), Academic Press
12. Steverding D., and Kadenbach B. Influence of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolin modification on proton translocation and membrane potential of reconstituted cytochrome c oxidase support 'proton slippage'. J. Biol. Chem. 266 (1991) 8097-8101
13. Kadenbach B., et al. The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim. Biophys. Acta 1655 (2004) 400-408
14. Sack M.N. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc. Res. 72 (2006) 210-219
15. Fruehauf J.P., and Meyskens Jr. F.L. Reactive oxygen species: a breath of life or death?. Clin. Cancer Res. 13 (2007) 789-794
16. Starkov A.A. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann. N. Y. Acad. Sci. 1147 (2008) 37-52
17. Fisher M. Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Rev. Neurol. Dis. 5 Suppl. 1 (2008) S4-S11
18. Ha H., et al. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res. Clin. Pract. 82 Suppl. 1 (2008) S42-S45
19. Budas G.R., and Mochly-Rosen D. Mitochondrial protein kinase Cepsilon (PKCε): emerging role in cardiac protection from ischaemic damage. Biochem. Soc. Trans. 35 (2007) 1052-1054
20. Halestrap A.P., et al. The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta 1767 (2007) 1007-1031
21. Busija D.W., et al. Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv. Drug Deliv. Rev. 60 (2008) 1471-1477
22. Otani H. Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 10 (2008) 207-247
23. Das M., and Das D.K. Molecular mechanism of preconditioning. IUBMB Life 60 (2008) 199-203
24. Murphy E., and Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88 (2008) 581-609
25. Kadenbach B., and Arnold S. A second mechanism of respiratory control. FEBS Lett. 447 (1999) 131-134
26. Helling S., et al. Phosphorylation and kinetics of mammalian cytochrome c oxidase. Mol. Cell. Proteomics 7 (2008) 1714-1724
27. Forman H.J., et al. The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch. Biochem. Biophys. 477 (2008) 183-195
28. Wang J., and Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol. Ther. 7 (2008) 1875-1884
29. Nauseef W.M. Biological roles for the NOX family NADPH oxidases. J. Biol. Chem. 283 (2008) 16961-16965
30. Ott M., et al. Mitochondria, oxidative stress and cell death. Apoptosis 12 (2007) 913-922
31. Liu S.S. Generating, partitioning, targeting and functioning of superoxide in mitochondria. Biosci. Rep. 17 (1997) 259-272
32. Korshunov S.S., et al. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416 (1997) 15-18
33. 2 production by membrane potential and NAD(P)H redox state. J. Neurochem. 86 (2003) 1101-1107
34. Miwa S., and Brand M.D. Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochem. Soc. Trans. 31 (2003) 1300-1301
35. Maragos W.F., and Korde A.S. Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury. J. Neurochem. 91 (2004) 257-262
36. Chen Q., et al. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am. J. Physiol. Cell Physiol. 292 (2007) C137-C147
37. Christophe M., and Nicolas S. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr. Pharm. Des. 12 (2006) 739-757
38. Iijima T. Mitochondrial membrane potential and ischemic neuronal death. Neurosci. Res. 55 (2006) 234-243
39. Lee I., et al. New control of mitochondrial membrane potential and ROS-formation. Biol. Chem. 382 (2001) 1629-1633
40. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochim. Biophys. Acta 1604 (2003) 77-94
41. Yoshikawa S., et al. Proton pumping mechanism of bovine heart cytochrome c oxidase. Biochim. Biophys. Acta 1757 (2006) 1110-1116
42. Hüttemann M., et al. Mammalian subunit IV isoforms of cytochrome c oxidase. Gene 267 (2001) 111-123
43. Lee I., et al. cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 280 (2005) 6094-6100
44. Fernández-Vizarra E., et al. Assembly of the oxidative phosphorylation system in humans: what we have learned by studying its defects. Biochim. Biophys. Acta 1793 (2009) 200-211
45. Barrientos A., et al. Suppression mechanisms of COX assembly defects in yeast and human: insights into the COX assembly process. Biochim. Biophys. Acta 1793 (2009) 97-107
46. Khalimonchuk O., and Winge D.R. Function and redox state of mitochondrial localized cysteine-rich proteins important in the assembly of cytochrome c oxidase. Biochim. Biophys. Acta 1783 (2008) 618-628
47. Dhar S.S., et al. Nuclear respiratory factor 1 regulates all ten nuclear-encoded subunits of cytochrome c oxidase in neurons. J. Biol. Chem. 283 (2008) 3120-3129
48. Iwata S., et al. Structure at 2.8 Å resolution of cytochrome c oxidase from Paracoccus denitrificans. Nature 376 (1995) 660-669
49. Ostermeier C., et al. Structure at 2.7 Å resolution of the Paracoccus denitrificans two-subunit cytochrome c oxidase complexed with an antibody FV fragment. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10547-10553
50. Tsukihara T., et al. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 Å. Science 272 (1996) 1136-1144
51. Yoshikawa S., et al. Redox-coupled crystal structural changes in bovine heart cytochrome c oxidase. Science 280 (1998) 1723-1729
52. Tsukihara T., et al. The low-spin heme of cytochrome c oxidase as the driving element of the proton pumping process. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15304-15309
53. 3-cytochrome c oxidase from Thermus thermophilus. EMBO J. 19 (2000) 1766-1776
54. Svensson-Ek M., et al. The X-ray crystal structures of wild-type and EQ(I-286) mutant cytochrome c oxidase from Rhodobacter sphaeroides. J. Mol. Biol. 321 (2002) 329-339
55. Dürr K.L., et al. A D-pathway mutation decouples the Paracoccus denitrificans cytochrome c oxidase by altering the side-chain orientation of a distant conserved glutamate. J. Mol. Biol. 384 (2008) 865-877
56. Namslauer A., et al. Plasticity of proton pathway structure and water coordination in cytochrome c oxidase. J. Biol. Chem. 282 (2007) 15148-15158
57. Sharpe M.A., and Ferguson-Miller S. A chemically explicit model for the mechanism of proton pumping in heme-copper oxidases. J. Bioenerg. Biomembr. 40 (2008) 541-549
58. Muramoto K., et al. A histidine residue acting as a controlling site for dioxygen reduction and proton pumping by cytochrome c oxidase. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7881-7886
59. Shimokata K., et al. The proton pumping pathway of bovine heart cytochrome c oxidase. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4200-4205
60. Salje J., et al. Is a third proton-conducting pathway operative in bacterial cytochrome c oxidase?. Biochem. Soc. Trans. 33 (2005) 829-831
61. Napiwotzki J., and Kadenbach B. Extramitochondrial ATP/ADP-ratios regulate cytochrome c oxidase activity via binding to the cytosolic domain of subunit IV. Biol. Chem. 379 (1998) 335-339
62. Arnold S., and Kadenbach B. Cell respiration is controlled by ATP, an allosteric inhibitor of cytochrome c oxidase. Eur. J. Biochem. 249 (1997) 350-354
63. Arnold S., and Kadenbach B. The intramitochondrial ATP/ADP-ratio controls cytochrome c oxidase activity allosterically. FEBS Lett. 443 (1999) 105-108
64. Horvat S., et al. Effect of hypoxia on the transcription pattern of subunit isoforms and the kinetics of cytochrome c oxidase in cortical astrocytes and cerebellar neurons. J. Neurochem. 99 (2006) 937-951
65. Spina D. PDE4 inhibitors: current status. Br. J. Pharmacol. 155 (2008) 308-315
66. Lee I., et al. Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol. Cell. Biochem. 234-235 (2002) 63-70
67. Prabu S.K., et al. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J. Biol. Chem. 281 (2006) 2061-2070
68. Fang J.-K., et al. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/reperfusion. FEBS Lett. 581 (2007) 1302-1310
69. Lee I., et al. Isolation of regulatory-competent, phosphorylated cytochrome c oxidase. Methods Enzymol. 457 (2009) 193-210
70. Tosaki A., et al. Preconditioning of rat heart with monophosphoryl lipid A: a role for nitric oxide. J. Pharmacol. Exp. Ther. 285 (1998) 1274-1279
71. Vogt S., et al. Regulation of oxidative phosphorylation by inhibition of its enzyme complexes via reversible phosphorylation. Curr. Enzyme Inhib. 3 (2007) 189-206
72. DiMauro S., and Schon E.A. Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31 (2008) 91-123
73. Debray F.G., et al. Long-term outcome and clinical spectrum of 73 pediatric patients with mitochondrial diseases. Pediatrics 119 (2007) 722-733
74. Krishnan K.J., et al. What causes mitochondrial DNA deletions in human cells?. Nat. Genet. 40 (2008) 275-279
75. Zee J.M., and Glerum D.M. Defects in cytochrome c oxidase assembly in humans: lessons from yeast. Biochem. Cell Biol. 84 (2006) 859-869
76. Massa V., et al. Severe infantile encephalomyopathy caused by a mutation in COX6B1, a nucleus-encoded subunit of cytochrome c oxidase. Am. J. Hum. Genet. 82 (2008) 1281-1289
77. Ghezzi D., et al. FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 83 (2008) 415-423
78. Samavati L., et al. Tumor necrosis factor α inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J. Biol. Chem. 283 (2008) 21134-21144
79. Shoubridge E.A. Cytochrome c oxidase deficiency. Am. J. Med. Genet. 106 (2001) 46-52
80. Filosto M., et al. Neuropathology of mitochondrial diseases. Biosci. Rep. 27 (2007) 23-30
81. Movsesian M.A. Therapeutic potential of cyclic nucleotide phosphodiesterase inhibitors in heart failure. Expert Opin. Investig. Drugs 9 (2000) 963-973
82. Kaim G., and Dimroth P. ATP synthesis by F-type ATP synthase is obligatorily dependent on the transmembrane voltage. EMBO J. 18 (1999) 4118-4127
83. Pecina P., et al. Genetic defects of cytochrome c oxidase assembly. Physiol. Res. 53 Suppl. 1 (2004) S213-S223
84. Fernandez D., and Perl A. Metabolic control of T cell activation and death in SLE. Autoimmun. Rev. 8 (2009) 184-189
85. Schon E.A., and DiMauro S. Mitochondrial mutations: genotype to phenotype. Novartis Found. Symp. 287 (2007) 214-225
86. Khoynezhad A., et al. A synopsis of research in cardiac apoptosis and its application to congestive heart failure. Tex. Heart Inst. J. 34 (2007) 352-359
87. Zeviani M., and Carelli V. Mitochondrial disorders. Curr. Opin. Neurol. 20 (2007) 564-571